Report Detail
Global Hemostasis and Tissue Sealing Agents Market Insights, Forecast to 2025
- RnM2473692 |
- 05 March, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent in 2017 is about 64%
North America is the largest consumption place, with a consumption market share nearly 42% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Hemostasis and Tissue Sealing Agents market is valued at 2810 million US$ in 2018 and will reach 4470 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemostasis and Tissue Sealing Agents market based on company, product type, end user and key regions.
This report studies the global market size of Hemostasis and Tissue Sealing Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemostasis and Tissue Sealing Agents in these regions.
This research report categorizes the global Hemostasis and Tissue Sealing Agents market by top players/brands, region, type and end user. This report also studies the global Hemostasis and Tissue Sealing Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Equimedical
Marine Polymer
Market size by Product
Hemostasis Agents
Tissue Sealing Agents
Market size by End User
Minimally Invasive Surgery
General Surgery
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hemostasis and Tissue Sealing Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemostasis and Tissue Sealing Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemostasis and Tissue Sealing Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemostasis and Tissue Sealing Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemostasis and Tissue Sealing Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemostasis and Tissue Sealing Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hemostasis and Tissue Sealing Agents Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hemostasis and Tissue Sealing Agents Market Size Growth Rate by Product
- 1.4.2 Hemostasis Agents
- 1.4.3 Tissue Sealing Agents
- 1.5 Market by End User
- 1.5.1 Global Hemostasis and Tissue Sealing Agents Market Size Growth Rate by End User
- 1.5.2 Minimally Invasive Surgery
- 1.5.3 General Surgery
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hemostasis and Tissue Sealing Agents Market Size
- 2.1.1 Global Hemostasis and Tissue Sealing Agents Revenue 2014-2025
- 2.1.2 Global Hemostasis and Tissue Sealing Agents Sales 2014-2025
- 2.2 Hemostasis and Tissue Sealing Agents Growth Rate by Regions
- 2.2.1 Global Hemostasis and Tissue Sealing Agents Sales by Regions
- 2.2.2 Global Hemostasis and Tissue Sealing Agents Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hemostasis and Tissue Sealing Agents Sales by Manufacturers
- 3.1.1 Hemostasis and Tissue Sealing Agents Sales by Manufacturers
- 3.1.2 Hemostasis and Tissue Sealing Agents Sales Market Share by Manufacturers
- 3.1.3 Global Hemostasis and Tissue Sealing Agents Market Concentration Ratio (CR5 and HHI)
- 3.2 Hemostasis and Tissue Sealing Agents Revenue by Manufacturers
- 3.2.1 Hemostasis and Tissue Sealing Agents Revenue by Manufacturers (2014-2019)
- 3.2.2 Hemostasis and Tissue Sealing Agents Revenue Share by Manufacturers (2014-2019)
- 3.3 Hemostasis and Tissue Sealing Agents Price by Manufacturers
- 3.4 Hemostasis and Tissue Sealing Agents Manufacturing Base Distribution, Product Types
- 3.4.1 Hemostasis and Tissue Sealing Agents Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hemostasis and Tissue Sealing Agents Product Type
- 3.4.3 Date of International Manufacturers Enter into Hemostasis and Tissue Sealing Agents Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hemostasis and Tissue Sealing Agents Sales by Product
- 4.2 Global Hemostasis and Tissue Sealing Agents Revenue by Product
- 4.3 Hemostasis and Tissue Sealing Agents Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hemostasis and Tissue Sealing Agents Breakdown Data by End User
6 North America
- 6.1 North America Hemostasis and Tissue Sealing Agents by Countries
- 6.1.1 North America Hemostasis and Tissue Sealing Agents Sales by Countries
- 6.1.2 North America Hemostasis and Tissue Sealing Agents Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hemostasis and Tissue Sealing Agents by Product
- 6.3 North America Hemostasis and Tissue Sealing Agents by End User
7 Europe
- 7.1 Europe Hemostasis and Tissue Sealing Agents by Countries
- 7.1.1 Europe Hemostasis and Tissue Sealing Agents Sales by Countries
- 7.1.2 Europe Hemostasis and Tissue Sealing Agents Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hemostasis and Tissue Sealing Agents by Product
- 7.3 Europe Hemostasis and Tissue Sealing Agents by End User
8 Asia Pacific
- 8.1 Asia Pacific Hemostasis and Tissue Sealing Agents by Countries
- 8.1.1 Asia Pacific Hemostasis and Tissue Sealing Agents Sales by Countries
- 8.1.2 Asia Pacific Hemostasis and Tissue Sealing Agents Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hemostasis and Tissue Sealing Agents by Product
- 8.3 Asia Pacific Hemostasis and Tissue Sealing Agents by End User
9 Central & South America
- 9.1 Central & South America Hemostasis and Tissue Sealing Agents by Countries
- 9.1.1 Central & South America Hemostasis and Tissue Sealing Agents Sales by Countries
- 9.1.2 Central & South America Hemostasis and Tissue Sealing Agents Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hemostasis and Tissue Sealing Agents by Product
- 9.3 Central & South America Hemostasis and Tissue Sealing Agents by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hemostasis and Tissue Sealing Agents by Countries
- 10.1.1 Middle East and Africa Hemostasis and Tissue Sealing Agents Sales by Countries
- 10.1.2 Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hemostasis and Tissue Sealing Agents by Product
- 10.3 Middle East and Africa Hemostasis and Tissue Sealing Agents by End User
11 Company Profiles
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Johnson & Johnson Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Johnson & Johnson Hemostasis and Tissue Sealing Agents Products Offered
- 11.1.5 Johnson & Johnson Recent Development
- 11.2 Baxter
- 11.2.1 Baxter Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Baxter Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Baxter Hemostasis and Tissue Sealing Agents Products Offered
- 11.2.5 Baxter Recent Development
- 11.3 C R Bard
- 11.3.1 C R Bard Company Details
- 11.3.2 Company Business Overview
- 11.3.3 C R Bard Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 C R Bard Hemostasis and Tissue Sealing Agents Products Offered
- 11.3.5 C R Bard Recent Development
- 11.4 B Braun
- 11.4.1 B Braun Company Details
- 11.4.2 Company Business Overview
- 11.4.3 B Braun Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 B Braun Hemostasis and Tissue Sealing Agents Products Offered
- 11.4.5 B Braun Recent Development
- 11.5 Gelita
- 11.5.1 Gelita Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Gelita Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Gelita Hemostasis and Tissue Sealing Agents Products Offered
- 11.5.5 Gelita Recent Development
- 11.6 Integra Life Sciences
- 11.6.1 Integra Life Sciences Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Integra Life Sciences Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Integra Life Sciences Hemostasis and Tissue Sealing Agents Products Offered
- 11.6.5 Integra Life Sciences Recent Development
- 11.7 Advance Medical Solution
- 11.7.1 Advance Medical Solution Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Advance Medical Solution Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Advance Medical Solution Hemostasis and Tissue Sealing Agents Products Offered
- 11.7.5 Advance Medical Solution Recent Development
- 11.8 Pfizer
- 11.8.1 Pfizer Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Hemostasis and Tissue Sealing Agents Products Offered
- 11.8.5 Pfizer Recent Development
- 11.9 CSL Behring
- 11.9.1 CSL Behring Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CSL Behring Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CSL Behring Hemostasis and Tissue Sealing Agents Products Offered
- 11.9.5 CSL Behring Recent Development
- 11.10 CryoLife
- 11.10.1 CryoLife Company Details
- 11.10.2 Company Business Overview
- 11.10.3 CryoLife Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 CryoLife Hemostasis and Tissue Sealing Agents Products Offered
- 11.10.5 CryoLife Recent Development
- 11.11 Zimmer Biomet
- 11.12 Ferrosan Medical Devices
- 11.13 Medtronic
- 11.14 Smith & Nephew
- 11.15 Z-Medica
- 11.16 Equimedical
- 11.17 Marine Polymer
12 Future Forecast
- 12.1 Hemostasis and Tissue Sealing Agents Market Forecast by Regions
- 12.1.1 Global Hemostasis and Tissue Sealing Agents Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hemostasis and Tissue Sealing Agents Revenue Forecast by Regions 2019-2025
- 12.2 Hemostasis and Tissue Sealing Agents Market Forecast by Product
- 12.2.1 Global Hemostasis and Tissue Sealing Agents Sales Forecast by Product 2019-2025
- 12.2.2 Global Hemostasis and Tissue Sealing Agents Revenue Forecast by Product 2019-2025
- 12.3 Hemostasis and Tissue Sealing Agents Market Forecast by End User
- 12.4 North America Hemostasis and Tissue Sealing Agents Forecast
- 12.5 Europe Hemostasis and Tissue Sealing Agents Forecast
- 12.6 Asia Pacific Hemostasis and Tissue Sealing Agents Forecast
- 12.7 Central & South America Hemostasis and Tissue Sealing Agents Forecast
- 12.8 Middle East and Africa Hemostasis and Tissue Sealing Agents Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hemostasis and Tissue Sealing Agents Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hemostasis and Tissue Sealing Agents . Industry analysis & Market Report on Hemostasis and Tissue Sealing Agents is a syndicated market report, published as Global Hemostasis and Tissue Sealing Agents Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hemostasis and Tissue Sealing Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
